News

EDC technology enables HGS to reach Phase 3 trial success for BENLYSTA™.

New method demonstrated by a team supported by NIH may help in efforts to pinpoint disease-causing genes.

The Companies combine their offerings to provide sensitive tools for interrogation specific cellular pathways via transcription factor reporters.

INTEGRA Biosciences AG and Viaflo Corporation have announced that they signed agreements to combine the two companies under the name of INTEGRA Viaflo Holding AG on July 23, 2009. The new group will be active across world markets under the brand "INTEGRA". This move follows the signing of a successful strategic marketing and distribution partnership around one year previously.

Eurofins MWG Operon now offers QuickLC purification for many custom oligonucleotides to life science companies and academic research institutions in the Americas.

Scientists develop a quantitative, mathematical model of DNA replication and cell division for the bacterium Caulobacter crescentus.

The study reports one-year gene therapy safety and efficacy results in treating young adults with Leber Congenital Amaurosis.

UC Irvine study has found that a gene called TOMM40 appears twice as often in people with Alzheimer's disease than in those without it.

Warnex will distribute Rosetta Genomics' three recently launched miRview™ tests in Canada.

EMBL scientists identify a rapid response team that monitors and quickly responds to DNA damage.